Hitachi Chemical Report issue

For profit Phase 2
Founded: Ibaraki Prefecture Japan (1910)
Status: No NME R&D (1910)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Hitachi, Ltd.

Active Ingredients

Drugs in Phase 2 Trials (2)

Key: Hitachi Chemical (0) Acquired (2)

bone marrow derived mesenchymal stem cells (1 trial)

msc_apceth_101 (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 2
  • # of Trial APIs: 2